Stay updated on Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.

Latest updates to the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page
- Check6 days agoChange DetectedParaganglioma was added to the study conditions and a Genetic and Rare Diseases Information Center resource was included. The page revision was updated from v3.4.3 to v3.5.0.SummaryDifference0.2%

- Check13 days agoChange Detected- Revision label updated to v3.4.3; previous revision v3.4.2 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedAdded Revision: v3.4.2 to the page. Deleted the government funding lapse notice and Revision: v3.4.1.SummaryDifference0.4%

- Check49 days agoChange DetectedA government funding notice banner was added to the page. The page version was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check56 days agoChange DetectedThe updates are minor copy edits and a version bump (Show glossary added; capitalization changes for 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'; Revision updated from v3.3.4 to v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check70 days agoChange DetectedThe page now displays Revision: v3.3.4, replacing the previous Revision: v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cabozantinib for Metastatic Pheochromocytomas Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib for Metastatic Pheochromocytomas Clinical Trial page.